Richard Payerchin

Alleged schemes include bribes, sham telehealth, unneeded heart and cancer testing.

Preliminary price forecasts could hint at industry trends for coming year.

Health systems, loaded with patient data, remain prime targets for computer attacks, feds say.

Fentanyl, COVID-19 pandemic likely factors in 30% increase from previous year.

Researchers analyze “conjunction fallacy” and find need for realistic expectations.

Study outlines trends in recruiting incentives, market conditions.

State budget includes $100 million for new program.

AHRQ Director Robert Otto Valdez says physicians and health care leaders must constantly ask what it means to provide high quality care.

Murthy offers five areas of transformation.

Clinical trial finds 90.4% effectiveness rating for those aged 18 years and older.

New position paper has five recommendations for financing, nursing homes, family caregivers.

AHRQ Director Robert Otto Valdez discusses the agency’s mission to assist primary care.

State regulations overruled to protect physicians’ clinical judgments.

Analysts predict rising prices, reimbursements, staff shortages could chip away at margins.

AHRQ Director Robert Otto Valdez discusses the state of the U.S. health care system.

Health agency leaders say tools are in place and deaths are preventable.

Federal, state laws put physicians in “impossible situation,” but they aim to work with legislators on policies.

FDA decision prompts praise from pharmacists for expanding treatment and equity around nation.

AHRQ Director Robert Otto Valdez explains the mission of the agency.

HHS to lead campaign with Attorney General and Federal Trade Commission for access and accurate information.

Ambulatory health, hospitals, home health care, nursing facilities all post gains.

HHS, Department of Justice lead investigations of fraud and abuse.

“Maui” ransomware is not about booking a Hawaiian getaway.

Oral antiviral pills may help adults and children avoid hospitalization and death.

Study examines links between physical and mental health and experiences with ageism.

Regulatory agency’s “marketing denial order” moves to court.

AMA, ATS, other organizations advocated for regulation over “global threat” of climate change.

HHS announces awards for facilities in rural and underserved communities across the nation.

Regulators remind physicians they are bound by federal privacy rules, but cell phones and apps are not.

Purchase follows FDA recommendation to include Omicron component in boosters.